Geneva College of Longevity Science launches to redefine longevity science education

GCLS aims revolutionize longevity education and propel innovation and collaboration in this rapidly accelerating field.

Geneva College of Longevity Science (GCLS) – the first higher education institution dedicated entirely to the rapidly developing field of longevity science – announced its launch today.

GCLS is set to offer comprehensive access to academic education in this dynamic area of study, a venture which it hopes will usher in an “era of innovation and collaboration.” Its faculty comprises interdisciplinary longevity experts from various fields, including genetics, medicine, pharmacy, gerontology, nutrition, psychology, and public health, and GCLS hopes that this range of knowledge and experience will ensure that students receive a comprehensive education that explores all facets of the expanding body of scientific insights available on extending human lifespan and improving quality of life.

Longevity.Technology: With global demographics shifting towards an aging population, the imperative for education in longevity science is becoming increasingly apparent; as populations age, the burden of age-related diseases and the strain on healthcare systems grow, necessitating proactive approaches to address these challenges at both practitioner and healthcare system level. The emergence of geroscience, an interdisciplinary field at the intersection of biology, medicine and genetics, underscores the need for a specialized education, and by bringing together experts from diverse fields, GCLS should ensure a comprehensive education that encompasses the latest scientific insights into extending human lifespan and improving quality of life.

It is interesting that the Executive Master of Science in Longevity program offered by GCLS is aimed not only at empowering professionals in the field to deepen their expertise, but will also equip policymakers and other stakeholders with the necessary knowledge to navigate the complexities of aging populations and healthcare policies

Dominik Thor is the President of the newly-launched GCLS

“Our commitment to fostering an environment of innovation, collaboration, and excellence is at the core of GCLS,” says Dominik Thor, President of GCLS. “Our Executive Master of Science in Longevity (EMSc Longevity) programme, designed in accordance with the Bologna process guidelines, is a testament to this commitment.”

The EMSc Longevity programme is a unique two-semester executive-level master’s distance learning program that covers a wide range of topics related to longevity science. Characterized by a high degree of flexibility to accommodate both professional and private responsibilities, the study programme empowers professionals in the field to deepen their knowledge and enhance their credibility. Designed for both practitioners seeking to deepen their understanding of cutting-edge longevity interventions and financial and policy decision-makers aiming to acquire expertise in this emerging healthcare field, the program offers a comprehensive, multidisciplinary approach covering the latest scientific findings associated with aging, health and longevity.

“I am incredibly proud of the work our team has put into bringing GCLS to life,” Thor adds. “I am excited about the opportunity to bring attention to academic education in longevity
science and invite everyone to join us and shape the future of longevity science together.”

GCLS also announced it has launched a new R&D project in collaboration with Dermatest GmbH, a leading dermatology research institute in Germay, and MOLEQLAR Analytics, a company that specializes in the detection and quantification of proteins and histone modifications.

Together, the collaboration aims to develop the first epigenetic test for assessing the efficacy of skincare products. GCLS said it believes that “introducing epigenetics as an innovative method for efficacy testing of cosmetic products will empower brands with stronger claims, while providing consumers with transparency in selecting the best product [1].”

Stay tuned for our interview with Dominik Thor, coming soon.


Photographs courtesy of GCLS